Drug recall · March 24, 2021
Nortriptyline HCL capsules recall
Why: cGMP deviations: The quantity of active ingredient used for the product lot was inadvertently taken from an ingredient lot from an alternate supplier before that specific lot was formally qualified for use by the manufacturing site.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Nortriptyline HCL capsules, 10 mg, packaged in 30-count bottles, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA, NDC 6191985330
- Lots / codes
Lot#: 28DE2002 Exp 10/31/22
- Quantity
- 17 bottles
- Company
- Direct Rx, Dawsonville, GA
- Distribution
- GA
- Initiated
- March 2, 2021 · Voluntary: Firm initiated
- Classified
- March 12, 2021
- Reported
- March 24, 2021
- Ended
- September 21, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Nortriptyline
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.